FindTrial
Sign In

Application in treatment and prognosis of circulating tumor cell detection in neuroblastoma

Application in treatment and prognosis of circulating tumor cell detection in neuroblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017864
Enrollment
Unknown
Registered
2018-08-18
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuroblastoma

Interventions

different risk groups:observational

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children with a diagnosis of neuroblastoma who had not received any treatment.

Exclusion criteria

Exclusion criteria: 1. Participation in a prior investigational study within 3 months prior to enrollment; 2. Other situations we think not eligible for participation in the research; 3. Patients with other major diseases.

Design outcomes

Primary

MeasureTime frame
progression-free survival;overall survival;—

Countries

China

Contacts

Public ContactDong Kuiran

Children's Hospital of Fudan University

kuirand@hotmail.com+86 18017591156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026